L2-based Human Papillomavirus Vaccines: Current Status And Potential

Home

Related articles

Challenges in HPV Vaccine Development and Supply

PM Kotulka, A Luxembourg, A Shaw
Current status of HPV vaccine in China

YL Qiao, MJ Gonzalez-Mendez, YQ Yu
Efficacy of HPV Vaccination To Prevent Vulvar and Vaginal Precancer

L Xu, SM Garland, M Arbyn
Impact of Bivalent HPV Vaccination in Scotland

R Cameron, K Cuschieri, K Roy
The impact of HPV vaccination program on CIN3 and cervical cancer incidence in England

K. Soldan, L. Elliss-Brookes, P. Sasieni
The value of HPV vaccines for the elimination of cervical cancer in China

H Yan, F Zhao, Y Qiao
Interview with Elmar Joura

EA Joura
Prevention of HPV-Related Diseases Following 4-Valent Vaccination in Australia

SM Garland, GL Murray, DA Machalek
Population-level Impact and Herd Effects of HPV Vaccination Programs in High-income Countries: Real-life Data

M Drolet, M Brisson
Pre-school HPV Immunization?

MA Kane, M Stanley
The time to act is now: elimination of cervical and other cancers caused by HPV in women and men

AR Giuliano, EA Joura
HPV vaccination crisis and recovery: the Danish case

L Baandrup, P Valentiner-Branth, SK Kjaer

HOME
Published material
Remembering our colleagues
About us
Contact us

Login

Change email Change password Activate service

Did you forget your password?

Do you want to subscribe?

Legal notice Privacy Policy

Copyright © 2023 HPV World All rights reserved